LYEL vs NDSN · $143.5M cap vs P/E 31, $16.17B cap
Lyell Immunopharma Inc (LYEL) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
Lyell Immunopharma Inc (LYEL) common stock.
Nordson Corporation (NDSN) common stock.
LYEL does not have a complete income-statement cache yet.
NDSN does not have a complete income-statement cache yet.
LYEL currently screens at market cap $143.5M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the LYEL and NDSN stock pages for the full models.
Not investment advice.